Chris Gemmiti is a regenerative medicine and cell and gene therapy specialist based in Boston. He focuses on early-stage translation, development, and commercialization within these fields, demonstrating a strong commitment to advancing innovative therapies. His insights reflect a deep passion for the progression of regenerative medicine technologies.

‌